Ralph L. Millett IV

Ralph Millett practices at Ochsner Medical Center - New Orleans in New Orleans, Louisiana, part of Ochsner Health System.

Ralph Millett's NPI, 1932563152, was assigned on April 13, 2016. Ralph Millett holds Louisiana license 337595.

Ralph Millett's primary practice is Ochsner Medical Center - New Orleans, at 1516 Jefferson Hwy, New Orleans, LA 70121 in Jefferson Parish. The practice phone is (504) 842-3000.

Ralph Millett's primary practice is Ochsner Medical Center - New Orleans in New Orleans, Louisiana, part of Ochsner Health System. Ralph Millett is also affiliated with Ochsner Medical Center - Baton Rouge. The medical group on file is Ochsner Health. Dmand AI also links Ralph Millett to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Ralph Millett practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Ralph Millett's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Ralph Millett's licenses on file in 2 states: Louisiana and District of Columbia.

CMS data shows 465 Medicare services from Ralph Millett across 5 procedure codes in 2024, for 80 Medicare patients. Medicare paid $32,729 for them.

CMS counts 80 Medicare patients who saw Ralph Millett in 2024. The largest group is 65 to 74, with 38 patients. 75% of them have cancer, and 75% have high blood pressure. 14% are also on Medicaid. Their average risk score is 2.08, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Ralph Millett's median patient age at 72, with 52% women.

In 2024, Ralph Millett wrote 558 Medicare Part D claims for 101 patients. 85% of them were for generic drugs. CMS names the drug for 409 of them, across 16 drugs with 11 or more claims each, at $283,371 in total drug cost. In 2023, CMS named 71 claims across 3 drugs.

Ralph Millett accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Ralph Millett as offering telehealth.

Dmand AI links 6 papers to Ralph Millett, published from 2018 to 2022. 2022 was the busiest year, with 2. The most frequent topics are Carcinoma, Non-Small-Cell Lung and Lung Neoplasms. Ralph Millett has published most often in Anticancer Res. Ralph Millett's most frequent co-authors are Jennifer Wilkinson Carlisle, MD, Andres Chang, MD, PhD and Jacob Matt Elkon, MD.

CMS Open Payments shows 39 general payments to Ralph Millett from 14 drug and device companies from 2023 to 2025. Consulting fees make up the largest share, 86% of the total. Genentech, Inc. paid the most, $9,139.